ºô¸®·çºó ÃøÁ¤±â ½ÃÀå : Á¦Ç°º°, ÀûÀÀÁõº°, ¿¬·É´ëº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ±âȸ ºÐ¼® ¹× »ê¾÷ ¿¹Ãø(2024-2033³â)
Bilirubin Meters Market By Product , By Indication By Age Group By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
»óǰÄÚµå : 1566952
¸®¼­Ä¡»ç : Allied Market Research
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 280 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,425 £Ü 6,181,000
PDF (Business License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 2¸í ÀÌ»óÀÌ ÀÌ¿ëÇÒ °æ¿ì, Ãß°¡ ¿ä±ÝÀ» ÁöºÒÇÏ¿© ¶óÀ̼±½º ¾÷±×·¹À̵å·Î ÃÖ´ë 5¸í±îÁö ÀÌ¿ë °¡´ÉÇÕ´Ï´Ù.
US $ 7,412 £Ü 10,353,000
PDF (Enterprise User License) & Excel (Data Pack) & Free Update help
PDF º¸°í¼­ ¹× Excel µ¥ÀÌÅ͸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. º¸°í¼­ ¾÷µ¥ÀÌÆ® ¼­ºñ½º°¡ ¹«·á·Î Á¦°øµË´Ï´Ù.


Çѱ۸ñÂ÷

ºô¸®·çºó ÃøÁ¤±â ½ÃÀåÀº 2023³â 12¾ï ´Þ·¯·Î Æò°¡µÇ¸ç 2024³âºÎÅÍ 2033³â±îÁö ¿¬Æò±Õ 7.6% ¼ºÀåÇÏ¿© 2033³â¿¡´Â 25¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºô¸®·çºó ÃøÁ¤±â´Â ÁÖ·Î ½Å»ý¾ÆÀÇ Ç÷Áß ºô¸®·çºó ³óµµ¸¦ ÃøÁ¤Çϱâ À§ÇØ ¼³°èµÈ ÈÞ´ë¿ë ÀÇ·á±â±âÀÔ´Ï´Ù. ºô¸®·çºó ¼öÄ¡ »ó½ÂÀº Ȳ´Þ·Î À̾îÁú ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ¿µ¾Æ¿¡°Ô ÈçÈ÷ ³ªÅ¸³ª´Â Áõ»óÀ¸·Î ¹æÄ¡ÇÏ¸é ³ú ¼Õ»óÀ» Æ÷ÇÔÇÑ ½É°¢ÇÑ °Ç°­ ¹®Á¦¸¦ À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÃøÁ¤±â´Â ºñħ½ÀÀûÀÌ°í ½Å¼ÓÇϰí Á¤È®ÇÏ°Ô ºô¸®·çºó ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÏ¿© Á¶±â ¹ß°ß ¹× Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. µû¶ó¼­ ½Å»ý¾Æ Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ÀÇ·á Àü¹®°¡°¡ Ãß°¡ °Ë»ç ¹× °³ÀÔÀÇ Çʿ伺¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¼¼°è ºô¸®·çºó ÃøÁ¤±â ½ÃÀåÀÇ ¼ºÀåÀº ½Å»ý¾Æ Ȳ´ÞÀÇ ½É°¢ÇÑ À¯º´·ü Áõ°¡¿Í ½Å»ý¾Æ Ȳ´ÞÀÇ Á¶±â Áø´Ü°ú Ä¡·á, ±×¸®°í Äɸ£´ÏÄÌ·¹ÅæÁõ°ú °°Àº ÇÕº´Áõ ¿¹¹æ¿¡ ´ëÇÑ Á߿伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. 2024³â 1¿ù »çÀ̾𽺠Á÷Á¢(Science Direct)°¡ ¹ßÇ¥ÇÑ ¿¬±¸¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î ¿¬°£ ¾à 110¸¸ ¸íÀÇ ½Å»ý¾Æ°¡ °íºô¸®·çºóÇ÷ÁõÀ» ¾Î°í ÀÖÀ¸¸ç, 2,000¸¸ ¸í ÀÌ»óÀÌ °íºô¸®·çºóÇ÷Áõ °ü·Ã ÇÕº´Áõ À§Çè¿¡ ³ëÃâµÇ¾î ÀÖ´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ, Ȳ´Þ¿¡ Ãë¾àÇÑ ¹Ì¼÷¾Æ Áõ°¡´Â ºô¸®·çºó ÃøÁ¤±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ´Â ¹Ì¼÷¾Æ´Â Á¾Á¾ ´õ ¸é¹ÐÇÑ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ºô¸®·çºó ÃøÁ¤±â°¡ ½Å»ý¾Æ ÁßȯÀڽǿ¡ ÇʼöÀûÀ̶ó´Â »ç½Ç¿¡ ±âÀÎÇÕ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â¿¡´Â ¾à 1,340¸¸ ¸íÀÇ ¹Ì¼÷¾Æ°¡ ž °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¿µ¾Æ »ç¸Á·ü °¨¼Ò¿Í ½Å»ý¾Æ °Ç°­ ÁõÁøÀ» À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡´Â ºô¸®·çºó ÃøÁ¤±â äÅÃÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇǺθ¦ ÅëÇØ ºñħ½ÀÀûÀ¸·Î ºô¸®·çºó ¼öÄ¡¸¦ ÃøÁ¤ÇÏ´Â ºñħ½ÀÀû ºô¸®·çºó ÃøÁ¤±â·ÎÀÇ ÀüȯÀº ÇöÀç ¼¼°è ½ÃÀå ¼ºÀåÀ» °­È­ÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â äÇ÷ÀÇ Çʿ伺À» ÁÙ¿© ½Å»ý¾Æ¿¡°Ô ½ºÆ®·¹½º¸¦ ´ú ÁÖ°í, ÀÇ·áÁø¿¡°Ôµµ È¿À²ÀûÀÎ °Ë»ç °úÁ¤À» Á¦°øÇÕ´Ï´Ù. ºñħ½ÀÀû µðÁöÅÐ ºô¸®·çºó ÃøÁ¤±â´Â Å« ÀåÁ¡ÀÌ ÀÖÁö¸¸, ƯÈ÷ Àú¼Òµæ Áö¿ª°ú ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³¿¡¼­ ³ôÀº ºñ¿ëÀÌ µµÀÔ À庮ÀÌ µÇ¾î ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤±âÀûÀÎ ºô¸®·çºó ¸ð´ÏÅ͸µÀÇ Á߿伺°ú ºô¸®·çºó ÃøÁ¤±â »ç¿ë¿¡ ´ëÇÑ ÀÇ·áÁøÀÇ Àνİú ±³À°ÀÌ ºÎÁ·ÇÏ´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÀúÇØ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó Á¦Á¶¾÷üµéÀº º´¿ø, Áø·á¼Ò, ½ÉÁö¾î ÀçÅÃÀÇ·á µî ´Ù¾çÇÑ È¯°æ¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ÀÛ°í »ç¿ëÇϱ⠽¬¿î ÈÞ´ë¿ë ¹× ÇöÀå ÃøÁ¤±â °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¾¼­ ±â¼úÀÇ Çõ½ÅÀº º¸´Ù Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ºô¸®·çºó ÃøÁ¤±â °³¹ß·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü¿¡´Â ´ÙÁß ½ºÆåÆ®·³ ¼¾¼­¿Í ¾îµÎ¿î ÇǺλöÀ» °¡Áø ¿µ¾Æµµ Á¤È®ÇÏ°Ô ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ¾Ë°í¸®ÁòÀ» »ç¿ëÇÏ¿© ±âÁ¸ ÀåºñÀÇ ÇѰ踦 ±Øº¹ÇÏ´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ½ÅÈï ½ÃÀå °³Ã´Àº ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¼¼°è ºô¸®·çºó ÃøÁ¤±â »ê¾÷Àº Á¦Ç°, ÀûÀÀÁõ, ¿¬·É´ë, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªÀ¸·Î ºÐ·ùµË´Ï´Ù. Á¦Ç°º°·Î ½ÃÀåÀº º¥Ä¡Å¾Çü°ú °æÇÇÇüÀ¸·Î ³ª´¹´Ï´Ù. ÀûÀÀÁõ¿¡ µû¶ó Ȳ´Þ°ú °£¿°À¸·Î ³ª´¹´Ï´Ù. ¿¬·É´ëº°·Î´Â ½Å»ý¾Æ¿Í ¼ºÀÎÀ¸·Î ±¸ºÐµË´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡ µû¶ó º´¿ø ¹× ¿ä¾ç ½Ã¼³, Ŭ¸®´Ð, ±âŸ·Î ºÐ·ùµË´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA·Î ºÐ¼®µË´Ï´Ù.

ÁÖ¿ä Á¶»ç °á°ú

Á¦Ç°º°·Î´Â °æÇÇ ºÎ¹®ÀÌ 2023³â ½ÃÀå Á¡À¯À²À» µ¶½ÄÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀûÀÀÁõº°·Î´Â Ȳ´Þ ºÎ¹®ÀÌ 2023³â ÁÖ¿ä ÁÖÁÖ¿´½À´Ï´Ù.

¿¬·É´ëº°·Î´Â ½Å»ý¾Æ°¡ 2023³â ÁÖ¿ä ºÎ¹®À¸·Î ºÎ»óÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º´¿ø ¹× ¿ä¾ç½Ã¼³ÀÌ 2023³â ÁÖ¿ä ºÎ¹®À¸·Î ºÎ»óÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇÁö¸¸, ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â »ç¿ëÀÚ Á¤Àǰ¡ °¡´ÉÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ºô¸®·çºó ÃøÁ¤±â ½ÃÀå : Á¦Ç°º°

Á¦5Àå ºô¸®·çºó ÃøÁ¤±â ½ÃÀå : ÀûÀÀÁõº°

Á¦6Àå ºô¸®·çºó ÃøÁ¤±â ½ÃÀå : ¿¬·ÉÃþº°

Á¦7Àå ºô¸®·çºó ÃøÁ¤±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ºô¸®·çºó ÃøÁ¤±â ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.

The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.

The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the transcutaneous segment dominated the market share in 2023.

On the basis of indication, the jaundice segment was the major shareholder in 2023.

As per age group, neonatal emerged as the leading segment in 2023.

Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.

Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Key Market Segments

By Region

By Product

By Indication

By Age Group

By End User

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET LANDSCAPE

CHAPTER 4: BILIRUBIN METERS MARKET, BY PRODUCT

CHAPTER 5: BILIRUBIN METERS MARKET, BY INDICATION

CHAPTER 6: BILIRUBIN METERS MARKET, BY AGE GROUP

CHAPTER 7: BILIRUBIN METERS MARKET, BY END USER

CHAPTER 8: BILIRUBIN METERS MARKET, BY REGION

CHAPTER 9: COMPETITIVE LANDSCAPE

CHAPTER 10: COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â